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Background: Garlic is one of the medicinal plants which has showed beneficial effects on atherosclerosis risk
factors. The liver X receptor α (LXRα) is an important regulator of cholesterol, triglyceride and glucose homeostasis
that belongs to the nuclear receptor superfamily. In this study we investigated the effect of garlic on lipid profile,
glucose as well as LXRα expression in intestine and liver of mice.
Methods: Forty male N-Mary mice were randomly divided into 3 groups (n = 8): group1 received chow + 2%
cholesterol + 0.5% cholic acid, group 2: chow + 4% (w/w) garlic extract + 2% cholesterol + 0.5% cholic acid, and
group 3: chow only. After one month of treatment, mice were anesthetized, blood was collected from their heart,
and the first 10 cm of the small intestine and liver were removed. Glucose was measured by a glucometer; other
biochemical factors were measured by enzymatic methods. LXR expression was checked by RT-PCR and western blotting.
Results: Compared with hypercholesterolemic mice, treatment with garlic extract significantly decreased total
cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, very low density lipoprotein-cholesterol (VLDL-C),
atherogenic index, alanine aminotranferease (ALT) and aspartate aminotransferase (AST) (all of them P < 0.05). Change
in HDL-C levels was not significant in garlic-extract treated animals compared with hypercholesterolemic group. LXR
protein and mRNA in the intestine were increased in garlic-extract treated group compared with chow group
(P < 0.05), while in the liver, only mRNA of LXR was increased in hypercholesterolemic control mice (P < 0.05).
Conclusions: The present study demonstrated that garlic extract reduced LXRα expression in the liver and increased its
expression in the intestine. These effects probably have an important role in reducing serum triglyceride and cholesterol.
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There are many risk factors for atherosclerosis including;
high levels of total cholesterol, low-density lipoprotein
cholesterol (LDL-C), triglycerides(TG) and a low level of
high-density lipoprotein cholesterol (HLD-C) [1,2]. Statins
which inhibit cholesterol synthesis are suggested as the
first line in lipid lowering treatment. Many patients can
not tolerate high doses of statins because of adverse ef-
fects, and the LDL-C levels are not adequately reduced,* Correspondence: 7abbasi@gmail.com
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distribution, and reproduction in any mediumthus in these patients, alternative or combination drug
treatment is a good option [3]. Garlic is one of the medi-
cinal plants which in many animal and human studies have
shown some beneficial effects on atherosclerosis risk fac-
tors. Many animal and human studies have shown that gar-
lic extract is very appropriate for many diseases, because
this medicine herb has a lot of useful effects, including; hy-
polipidemic and hypocholesterolemic effects, antimicrobial
and antifungal activity, anticarcinogenic activities, antioxi-
dant activity, anti-hypertensive activity, anti-diabetic, anti-
hyperhomocysteinemia and antithrombotic effects [4].
The livers X receptors (LXRα (NR1H3) and LXRβ
(NR1H2)) are important regulators of cholesterol, triglycer-
ide and glucose homeostasis that belong to the nuclear re-
ceptor superfamily. LXRs with regulation of ATP-bindingoMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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reverse cholesterol transport. It has been demonstrated that
LXRα agonists effectively block intestinal cholesterol ab-
sorption. LXRα also plays a role in cholesterol storage and
steroidogenesis pathways [5,6]. Wang Y, et al. have been
shown that LXRα plays vital role in the controlling of chol-
esterol biosynthesis via directly silencing the expression
of two main enzymes (squalene synthase and lanosterol
14α-demethylase (CYP51A1)) [7]. Zelcer N, et al. reported
that LXRα regulate cholesterol metabolic by inducing of
cholesterol exclusion and reverse cholesterol transport
[8]. Resveratrol which has known as hypoglycemic and
hypolipidemic agent inhibit lipogenesis in hepatocytes
via LXRα-mediated mechanism [9]. Mohammadi, et al.,
showed that flaxseed significantly reduced lipid profile
through activation of LXRα in the intestine and inhib-
ition of LXRα in the liver [10]. Zhang Y, et al. sug-
gested that activation of LXRs (except hepatic LXRs)
have beneficial effect for cardiovascular disease treat-
ment [11]. In this experiment we have investigated the
useful effects of garlic on lipid profile and expression
of LXR alpha, which is involved in lipid and carbohy-




Forty male N-Mary mice were purchased from the ani-
mal house of Kerman University of Medical Sciences.
Animals were maintained on a 12 h light/12 h dark
cycle at 22 ± 1°C. After one week for acclimatization,
they were randomly divided into 3 groups (n = 8):
group1 (hypercholestrolemic group) received chow +
2% cholesterol + 0.5% cholic acid, group 2 (garlic
treated group) received chow + 4% (w/w) garlic extract +
2% cholesterol + 0.5% cholic acid, and group (chow group)
received chow only. Blood glucose, TG and cholesterol
were measured before starting treatment. This study was
approved by the Animal Research Ethics Committee of
Kerman University of Medical Sciences, Kerman, Iran.
Preparation of water garlic-extract
Garlic was purchased from the market. Cloves of garlic
were washed with distilled water, crushed and dried.
Twenty grams of shadow dried crusehd garlic was pulver-
ized and macerated in 200 ml of distilled water at room
temperature for 24 h. After filtration, the extract was dried
at 40°C in an incubator for 24 h. The extract was kept in
dark vials at −20°C.
Preparation of garlic-extract supplemented chow
Garlic extract (4 g per 100 g of chow) was dissolved in
normal saline and mixed with chow. The same amountof normal saline was added to the diets of hypercholes-
terolemic and chow groups.
Animal treatments and preparation of serum, liver and
intestine tissues.
Depending on the group that they were assigned to, ani-
mals had free access to garlic-extract supplemented, choles-
terol supplemented, or normal chow. They were monitored
daily and body weight was recorded every two days [12].
After one month of treatment, food was removed 12 hrs
before the experiments. Mice were anesthetized with di-
ethyl ether, and blood was collected from their hearts. Duo-
denum and liver were removed, washed with phosphate
buffered saline (PBS), and stored in – 70°C till use. Liver
was weighed before freezing.
Biochemical factors
Serum was obtained by centrifugation of blood samples at
3000 g for 10 minutes and stored at −20°C until assay.
HDL-C, total cholesterol, triglycerides, alanine amino-
transferase (ALT) and aspartate aminotransferase (AST)
activities were analyzed using commercial kits (Pars
Azmon, Tehran, Iran). Fasting blood glucose was mea-
sured by a glucometer (Roche). The LDL-C and VLDL-C
levels were calculated using Friedwald equation. Athero-
genic index (AI) was calculated using the following equa-
tion [12-17]:
Atherogenic index ¼ total cholesterol− HDL−Cð Þ
HDL−C
Reverse transcriptase PCR (RT-PCR)
Frozen liver and intestine were used to extract RNA.
Total RNA from liver and intestine were extracted using
Accuzol Reagent (Bioneer, Korea) according to the man-
ufacturers’ protocol.
Synthesis of cDNA was performed according to the
manufacturer’s protocol (Fermentas, Lithuania). briefly,
1 μl forward primer, 1 μl reverse primer, 12 μl PCR
Master Mix, 2 μl cDNA and 9 μl deionized water were
added into a sterile pipe on ice. For RT- PCR reaction,
thirty five cycles of PCR amplification were performed
with denaturation at 95°C for 30 s, annealing at 63°C for
30 s, and extension at 72°C for 30 s using a PCR ma-
chine. All PCR reactions were completed with a single
extension cycle at 72°C for 5 minutes. The products
were electrophoresed on a 2.5% agarose gel and visual-
ized by staining with ethidium bromide. The following
primers were used in this study. Mouse LXR alpha pri-
mer; F: 5′-GCG TCC ATT CAG AGC AAG TGT-3′
and R: 5′-TCA CTC GTG GAC ATC CCA GAT-3′.
Mouse Beta actin Primer; F: 5′-TGG AAT CCT GTG
GCA TCC ATG AAA C-3′ and R: 5′-TAA AAC GCA
GCT CAG TAA CAG TCC G-3′ [13,15,18,19].
Table 1 Comparison of biochemical factors between
different treatment groups
Biochemical factors Hypercholesterolemic Garlic Chow
Body weight (g) 37.5 ± 1.5f 35.7 ± 0.8 30.7 ± 0.7
FBS (mg/dl) 160.1 ± 5.6 152.7 ± 4.6 138.1 ± 9.7
TC(mg/dl) 230.1 ± 4.5f 191.4 ± 5.4a 129 ± 13.4
TG (mg/dl) 160.5 ± 7.5d 137.4 ± 4.5a 133.5 ± 4.0
VLDL-C (mg/dl) 32.1 ± 1.5d 27.5 ± 0.9a 26.7 ± 0.8
HDL-C (mg/dl) 90.3 ± 8.1 106.2 ± 3.8c 87.4 ± 9.7
LDL-C (mg/dl) 98.8 ± 7.8f 57.6 ± 7.4a 24.9 ± 5.5
AI 1.6 ± 0.08f 0.8 ± 0.02b 0.48 ± 0.01
FBS: Fasting blood sugar, TC: Total cholesterol, TG: Triglyceride, HDL-C:
High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol,
VLDL-C: Very low-density lipoprotein cholesterol, AI: atherogenic index. Data
represent as mean ± SEM (n = 8).
ap < 0.05, bp < 0.01 and cp < 0.001 garlic group compared with
hypercholestrolemic. dp < 0.01 and fp < 0.001 hypercholestrolemic group
compared with chow.
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For protein analysis 50 mg of liver or intestine were ho-
mogenized in 700 μl of RIPA buffer containing 1% protein
inhibitor cocktail (Santa Cruz, USA) and 1 μM PMSF,
then centrifuged (14000 rpm at 4°C for 15 minutes). Pro-
tein concentration of the samples was measured in a Nano
Drop spectrophotometer and 120 μg of protein was loaded
on a 12.5% SDS-PAGE gel. After electrophoresis, proteins
were transferred to a PVDF (Roche Applied Science)
membrane. The Membrane was blocked with 3% skim
milk in Tris-buffered saline containing Tween-20 (TBS-T)
(Roche Applied Science) for 2 hrs at room temperature.
The membrane was washed (three times, 15 min each) in
TBS-T and then incubated with primary antibody for
1.5 hrs with anti rabbit polyclonal antibody LXR (1:300 di-
lution, Novus Biological (NB400-157)). After 3 washes
in TBS-T, the blots were incubated with horseradish
peroxidase-conjugated anti-rabbit IgG (1:10,000 dilutions,
Roche Applied Science) at room temperature for 1.5 hrs.
The membranes were washed and exposed to ECL west-
ern blotting detection reagents (Roche Applied Science)
and then exposed to films for 30s to 1 minute. Films were
developed, scanned, and band densities were measured
with Lab Work analyzing software (UVP, UK). Data are
expressed as the percent ratio of the protein bands to β-
Actin band [10,13,16].Table 2 Comparison of liver enzyme between different
treatment groups
Biochemical factors Control Garlic Chow
AST (IU/L) 59.5 ± 4.5 43.7 ± 4.1* 42.5 ± 5.2
ALT (IU/L) 61.7 ± 4.6 42.1 ± 3.7* 41.5 ± 4.0
AST: Aspartate aminotransferase, ALT: Alanine aminotransferase. *p < 0.05
garlic compared with control (hypercjolesterolemic) (n = 8).Statistical analysis
All results are presented as mean ± S.E.M. Statistical ana-
lysis of the results was done with one-way analysis of vari-
ance with ANOVA (Tukey). SPSS 14.0 for windows (SPSS
Inc., Chicago, USA) was used for data analysis and differ-
ent were considered significant at P < 0.05.
Results
Biochemical factors
Table 1 shows body weight, FBS, TC, LDL-C, HDL-C, TG
and VLDL-C, in mice fed a high cholesterol diet, garlic ex-
tract and chow. There was a non significant reduction in
blood glucose in garlic extract- treated group in compari-
son with hypercholestrolemic group. Serum TC, LDL-C,
TG and VLDL-C significantly decreased in garlic extract-
treated group. Change in serum HDL-C levels was not sig-
nificant in garlic extract-treated group compared with
hypercholestrolemic group, but markedly increased in
comparison with chow. Table 2 shows AST and ALT in
mice fed a high cholesterol diet, garlic extract and chow.
RT-PCR analysis
PCR products of LXR showed an expected band of 88 bp
respectively. Intestinal and liver LXR mRNA markedly in-
creased in garlic extract treated group compared with
others groups (P < 0.05) (Figures 1 and 2).Immunoblot analysis
Immunoblot analysis of the intestine and liver protein
probed with anti LXR revealed bands with expected size
of 64 KDa. Intestine LXR markedly increased in garlic
extract-treated group hypercholesterolemic control (P <
0.05), while the LXR in liver was significantly reduced in
garlic extract treated group (Figures 3 and 4).
Discussion
Many human and animal studies, mostly short term,
have investigated the lipid lowering effects of garlic.
Cheng et al. showed that the maximum tolerable level of
water-extracted garlic in diet was 10% in mice [20]. In
the present study, we used a diet containing 4% w/w gar-
lic extract in order to be well tolerated by the animals.
Adding the garlic extract to the food did not change the
food intake and body weight. Results from Yu-Yan Yeh
et al. study suggest that the water-soluble sulfur com-
pounds in garlic inhibit cholesterol synthesis, whereas
the inhibition by lipid-soluble extracts results from the
strong cytotoxic effect of this extract [21]. They also
showed that water-extract inhibited cholesterol synthesis
more efficiently than methanol-extractable fraction and
petroleum ether-extractable fraction [21]. Therefore, we
used water extract in this experiment.
In our study garlic extract significantly reduced total
serum cholesterol (16.9%), LDL-C (30%), triglycerides
Figure 1 Levels of LXR mRNA in the intestine of control
(hypercholesterolemic), garlic and chow groups (n = 6–8).
Level of LXR mRNA was increased in garlic group compared with
hypercholesterolemic group (*p < 0.05). Data are presented
as mean ± SEM.
Figure 2 Levels of LXR mRNA in the liver of control
(hypercholesterolemic), garlic and chow groups (n = 6–8).
LXR mRNA level was reduced in garlic group compared with
hypercholesterolemic group (*p < 0.05). Data are presented
as mean ± SEM.
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terolemic control (cholesterol 2% and 0.5% cholic acid).
Elmahdi B et al. reported that adding 8% raw garlic
along with 2% cholesterol to rat diet, decreased plasma
total cholesterol and LDL-C and increased HDL-C [22].
LDL-C reduction by garlic extract may be due to de-
creases of hepatic 3-hydroxy-3-methylglutaryl-CoA re-
ductase, cholesterol 7α-hydroxylase, pentose-phosphate
pathway activities [23], cholesteryl ester transfer protein
activity [24], microsomal triglyceride transfer protein
[25], increased bile acid excretion [26] and inhibition of
hepatic fatty acid synthesis [27]. Aouadi et al. showed
that adding 10% fresh crushed garlic and 2% cholesterol
to diet led to significant reduction in LDL-C levels, and in-
creased HDL-C levels in rats [28]. In our study, HDL-C
level was significantly increased in garlic extract group
compared to chow group. The results of our study also
show that fasting blood glucose levels decreased in gar-
lic group compared with hypercholesterolemic group
but, it was not significant. Aouadi R and Ali M, [28,29]
reported that garlic has no effect on blood glucose.
Similar to Ali M et al. [29] in our study there was no
change in body weight in the groups that consumed a
high cholesterol diet with garlic. In the present study,
we found that garlic extract significantly reduced
plasma levels of ALT and AST. Furthermore, the ob-
served decrease in serum AST and ALT activities by gar-
lic extract also reflects decreased high cholesterol diet
induced hepatocyte injury in mice.
Overall activation of LXR with synthetic agonists has sev-
eral effects; hypertriglyceridemia, high HDL levels, hepatic
steatosis, increased excretion of biliary cholesterol, reduced
absorption of intestinal cholesterol and increased fecal neu-
tral sterol excretion. LXRα activation in intestine leads to
reduction of intestinal cholesterol absorption via increased
ABCG5 and ABCG8 expression and reduction of intestinal
NPC1L1 expression [6]. Furthermore, activation of LXR
leads to markedly increased levels of ABCA1 mRNA and
consequently increased HDL levels. Not only LXR agonist,
but also high cholesterol, up-regulated expression of these
genes via LXR, so it has been proposed that biological role
of LXR is to recognize high concentrations of intracellular
cholesterol and to prevent of cholesterol accumulation in
the cell [5,30]. In this study garlic markedly increased LXR
mRNA and protein in the intestine. We showed that garlic
significantly reduced intestinal NPC1L1 expression and in-
creased ABCG5 and ABCG8 expression in the intestine
(unpublished). Therefore, we can conclude that decrease of
blood cholesterol and LDL-C levels maybe is due to upreg-
ulation of intestinal NPC1L1, ABCG5 and Abcg8 expres-
sion via LXRα [5].
In rodents, LXRα increases catabolism of hepatic choles-
terol and formation of bile acids by provoke of cholesterol
7α-hydroxylase, the rate-limiting enzyme which convert
Figure 3 Levels of LXR protein in the intestine of control (hypercholesterolemic), garlic and chow groups (n = 6–8). LXR expression was
increased in garlic group compared with hyppercholesterolemic group (*p < 0.05). Data are presented as mean ± SEM.
Figure 4 Levels of LXR protein in the liver cells of control
(hypercholesterolemic), garlic and chow groups (n = 6–8).
LXR protein expression was reduced in garlic group compared with
hypercholesterolemic group (*p < 0.05). Data are presented
as mean ± SEM.
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undesirable effects that cause steatosis and hypertriglyc-
eridemia through stimulation of de novo hepatic lipo-
genesis via activating the transcription of lipogenic
genes. A previous experiments showed that treatment
with an LXRα agonist provoke the expression of lipo-
genesis genes [5,31].
In addition to cholesterol homeostasis LXRs have also
been revealed to control biosynthesis of hepatic fatty
acid. This procedure is governed by sterol regulatory
element binding protein-1c (SREBP-1c) that regulates
all the genes involved in this pathway, including acetyl-
CoA carboxylase (ACC), fatty acid synthase (FAS) and
stearoyl-CoA desaturase (SCD). Administration of LXR
agonist, T0901317, raises hepatic expression of SREBP-
1c, FAS, ACC, and SCD in wild type mice. T0901317-
induced activation of lipogenesis leads to huge hepatic
triglycerides accumulation and eventually to liver stea-
tosis, liver dysfunction, and hypertriglyceridemia [5,6].
In the present study, we observed that garlic extract sig-
nificantly reduced liver LXR α expression. Therefore,
with reduction of liver LXR expression by garlic extract,
we propose one of the mechanisms which garlic leads to
reduction of blood triglyceride levels is this route.
Conclusion
In summary, the present study demonstrated that garlic
extract antagonized LXRα expression in the liver while;
provoke LXRα expression in the intestine. Reverse ex-
pression of LXRα in these tissues maybe have important
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Combining this new result with prior information col-
lected about the LXR importance and garlic useful proper-
ties it is probable to make this suggest that garlic could
use as a potential agent to treatment of diabetes and CVD.
Future studies need to investigate and approve garlic as a
potential therapeutic target and LXR agonist.
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